This report to the Executive Board is a forward-looking document highlighting the achievements, lessons learned, goals, policies, strategies and approaches for the Expanded Programme on Immunization for the 1990s. The Programme's Global Advisory Group endorsed the report in October 1991，together with actions proposed for the 1990s. The Executive Board may wish to consider a resolution along the lines of a proposed draft resolution suggested by the Programme's Global Advisory Group, that will be distributed during the Executive Board meeting.
1.
For the Expanded Programme on Immunization (EPI), the past decade has been one of building national immunization systems, with the primary focus on developing countries and with the primary objective of expanding coverage as quickly as possible. National programmes, backed by an impressive coalition of national and international partners, have for the most part now succeeded in establishing systems which reach the majority of children attaining one year of age with a protective course of immunizations.
5.
In 1986 the Health Assembly assessed progress since 1982. It again warned that continuing acceleration of national programmes would be needed to meet the 1990 goal and urged Member States to pursue vigorously three general and four specific recommendations by the Director-General (resolution WHA39.30). In 1988, in light of global immunization progress, the Health Assembly declared the commitment of WHO to the global eradication of poliomyelitis by the year 2000, emphasizing that eradication should be pursued in ways which strengthen the development of EPI as a whole, fostering its contribution, in turn, to the development of primary health care (resolution WHA41.28). The next year the Health Assembly adopted resolution WHA42.32 raising awareness to the challenges, in addition to poliomyelitis eradication, of measles reduction, neonatal tetanus elimination, improving surveillance, introducing new or improved vaccines, promoting other primary health care practices, and achieving and maintaining 90% immunization coverage with all EPI vaccines.
ACHIEVEMENTS

6.
The global achievement of the 1990 target of 80% immunization coverage among infants world wide with BCG and measles vaccines, and the third dose of DPT and of oral poliovirus vaccines (see Figure 1) represents a milestone on the way to universal childhood immunization. This progress in global immunization is directly attributable to the efforts of national governments, WHO, UNICEF and other bodies of the United Nations system, bilateral development agencies, and nongovernmental organizations such as Rotary International. The development of the capacity to achieve these levels of coverage of infants represents a major public health triumph for the decade of the 1980s.
7.
Global statistics, however, mask disparities among regions (see Figure 2) , countries (see Figures 3 and 4) , states/provinces, and districts. Differences in immunization coverage levels reflect, in part, the varied development of the primary health care infrastructure and are one of the measures of the degree of equity and social justice that communities have achieved. Also, the much lower coverage of 39% reported for tetanus toxoid for pregnant women in developing countries to protect their newborns from neonatal tetanus serves as a reminder that neonatal tetanus was the "forgotten" vaccine-preventable disease of the past decade, partly owing to the fact that efforts for its prevention are directed to a target population different from infants. 8. At current levels of immunization coverage, it is estimated that immunization programmes prevent each year some 3.2 million deaths from measles, neonatal tetanus and pertussis, as well as some 440 000 cases of paralytic poliomyelitis (see Figure 5) . The occurrence each year of an estimated 1.7 million deaths from these same diseases, and some 120 000 cases of paralytic poliomyelitis underlines the urgent need to continue raising immunization coverage levels and to focus on control of the target diseases. The 1-2 million deaths attributable to hepatitis В infection emphasizes the importance of adding new vaccines.
LESSONS LEARNED
9. The worldwide immunization effort over the past 15 years has demonstrated that a global coalition, sharing common goals, can create an unprecedented degree of cooperation among all peoples, including a wide spectrum of national governments and international, national and local organizations.
10. The development of immunization programmes over these years has taught specific lessons that will continue to guide immunization programmes in the 1990s. For example:
-nearly all children of the world and their mothers can be reached with immunization services which provide an excellent entry point for other primary health care interventions and significantly reduce mortality, morbidity, and disability; -personal involvement of heads of State and political, religious and social leadership at all levels generates political will, creates demand for immunization services, mobilizes communities and can even overcome such obstacles to immunization as low levels of socioeconomic development, and civil war (for instance by promoting "days of tranquillity"); -goals set by the World Health Assembly help to galvanize the international community into action;
• policies and strategies recommended by the EPI Global Advisory Group provide a common direction for immunization efforts; -motivated and trained senior managers at global, regional and country levels have helped to set up the basic structure of the programme and to develop it continuously in the light of experience gained from the field; -the effective coalition between national governments, bodies of the United Nations system, bilateral development agencies, nongovernmental organizations and countless communities resulted in a rapid improvement in immunization coverage and demonstrates that a preventive health strategy can mobilize cooperation on a global scale; -communication is a critical component of immunization programmes and should be planned and designed as an integral part of the programme. Successful programmes are based on audience research and use multiple channels (face-to-face, print, mass media) to deliver the action-oriented message;
-inclusion of only essential and proven cost-effective elements in immunization interventions is a factor in their success;
-successful programmes have a process measure (e.g. immunization coverage) as well as an outcome indicator (e.g. disease incidence); -decentralization of resources, coupled with national plans of action, permits countries to plan and execute activities more effectively and rapidly;
• research and development in logistics, the cold chain, injection equipment, new and improved vaccines, delivery strategies, immunization schedules, and monitoring and evaluation methodologies provide a technical basis for advancing programme policies and strategies;
-training provides the technical skills for planning and management to strengthen the health infrastructure and to develop the needed human resources at senior, middle and peripheral levels;
-emphasis on surveillance strengthens all aspects of an immunization programme and helps to focus efforts on areas at highest risk;
-unwarranted contraindications to immunization, unbalanced concerns over adverse reactions of vaccines compared to the risks of disease, and public apathy towards immunization as disease incidence declines are phenomena, seen especially in developed countries, that must be countered everywhere;
-the need to share lessons learned between developing and developed countries is increasingly important as immunization coverage rates reach similar levels and as common problems are recognized, such as unimmunized groups in urban areas and breaks in the cold chain.
11. Some diseases can be effectively controlled and even eradicated. In addition to the important humanitarian goal of averting needless suffering, the cost of a control effort saves money by reducing the numbers of patients treated, and the cost of an eradication effort can result in additional savings by halting the need to immunize against the diseases.
12. The achievements and lessons learned provide grounds for optimism that the new challenges facing immunization programmes in the decade of the 1990s will be met. 14. The following additional targets are proposed for immunization programmes for the 1990s to help to ensure the equitable distribution of immunization services and to control better the EPI target diseases, to quantify indicators for improving disease siurveiilance, and to specify new vaccines and a mechanism for their introduction into immunization programmes in the countries in greatest need. 15. Improving immunization coverage beyond 80% and achieving the disease control targets will be more difficult than reaching the 80% immunization coverage target for 1990 since efforts will need to be targeted toward high risk, perhaps difficult to reach, populations. Ibis means that immunization programme managers will have to improve the information system to identify pockets of unimmunized children and areas of continued disease transmission as well as expend greater efforts to determine which aspects of the programme need to be enhanced to reach them. Increased resources to intensify the delivery system and strengthen capabilities for outbreak response will be required.
GOALS
POLICIES AND STRATEGIES
The World Health
Assembly has provided general guidance on the policies to achieve immunization-related goals by stating in resolution WHA42.32 that "efforts should be pursued in ways which strengthen the development of the Expanded Programme on Immunization as a whole, fostering its contribution, in turn, to the development of the health infrastructure and of primary health care".
17. Thus, immunization and other highly cost-effective interventions will serve as a "leading edge" for a more comprehensive primary health care system. The disease control goals (measles reduction, neonatal tetanus elimination, and poliomyelitis eradication) serve as a driving force to ensure maximum impact and identify remaining pockets of susceptible individuals. A focus on these diseases will keep the spotlight on the health of children and mothers and direct programme resources to the areas of greatest need.
18. The disease control goals will also enhance all aspects of immunization programmes, including improving coverage, assuring adequate supply of effective vaccines, setting up surveillance systems, collecting and analysing programme information and taking appropriate action.
The specific benefits of a disease-oriented focus for the policies and strategies of immunization programmes in the 1990s include:
-identifying high-risk areas with low immunization coverage and conducting intensified immunization activities in these underserved areas. This can also help to develop and sustain community participation and to strengthen the infrastructure needed to introduce other essential primary health care;
-strengthening the surveillance systems for EPI target diseases, and other diseases of high priority, so that they may provide "information for action" that will also contribute to developing national capabilities for timely and complete reporting, to laboratory support, and to outbreak investigation and control;
-serving as an indicator of programme quality by pinpointing vaccine failures due to deficiencies of manufacture, storage, transport and administration of vaccine;
• determining priorities for research and development on new and improved vaccines against the main causes of mortality, morbidity, and disability; -in the case of a successful control or eradication effort, allowing savings of money to be allocated to other public health priorities; and
• helping to sustain political will and donor commitment for EPI and other essential primary health care by demonstrating an impact which results in decreasing incidence of the target diseases.
20. The global plans of action for the specific disease control goals of measles reduction, neonatal tetanus elimination, and poliomyelitis eradication include recommended policies and strategies. These policies and strategies continue to be refined in the light of recommendations of the EPI Global Advisory Group as additional experiences are gained. Regions and countries should form technical advisory groups that will assist in adapting such policies and strategies to the unique opportunities and constraints that exist in each region and country. The process of decentralizing decision-making and planning to the local level will help the sustainability of immunization programmes.
21. There will also be a need to elaborate policies and strategies specific to urban areas. All regions are experiencing rapid urbanization and it is expected that half the world's population will reside in cities by the year 2000. Urban areas will have to increase their immunization efforts with an emphasis on identifying those responsible for ensuring the provision of immunization services in each area of the city. Cities may also serve as reservoirs for vaccine-preventable diseases such as measles, and so, for example, controlling measles in cities may be critical to global measles control. Cities present unique opportunities for creative approaches, as well as special challenges that will have to be addressed. It is appropriate for maturing immunization programmes to lead the way for improved urban health by helping to bring integrated primary health care into the cities and by initiating needed policy dialogue on urban health issues.
RESOURCES
22.
The new goals of measles reduction, neonatal tetanus elimination and poliomyelitis eradication and the activities to achieve the immunization coverage goals will require significantly more resources, including more vaccine. Strategies to achieve these and other goals must be evaluated and prioritized using information that includes the cost implications and impact on available resources such as vaccines, staffing, equipment and budgets. Information on the resource needs of various strategies will be gathered throu^i selected programme reviews to determine their effectiveness and the inherent trade-offs between different strategies.
23. Resource limitations are perhaps the greatest constraint on achieving the EPI goals of the 1990s. To overcome these limitations, immunization programmes need to strengthen and broaden a donor constituency. Public awareness of the benefits of immunization is necessary not only in developing countries, but in the industrialized donor countries as well. Immunization programmes in many developing countries are dependent, in part, on the contributions of donors that could be enhanced if the public understood better the benefits of global immunization.
24. The public's knowledge and awareness of the benefits of achieving the immunization goals will be raised by designing, in collaboration with the donor community, a global communications strategy for H EPI for the 1990s". 25. The Global Advisory Group of EPI has recommended that a global interagency coordinating committee be established to complement regional and national interagency coordinating committees in helping to mobilize the additional resources required. This committee will foster more effective communication and enhance participation among all current and potential partners in immunization programmes.
PLANNING AND COORDINATION
26. Immunization and disease control plans of action will be formulated at all levels, reviewed periodically, and revised as necessary to establish policies and strategies and set priorities on activities to meet the goals. Plans for achieving specific immunization coverage and disease control targets should be part of an overall immunization plan of action. This, in turn, should be an integrated component of the primary health care strategy. The formation and strengthening of technical advisory groups at regional and country levels, similar in function to the EPI Global Advisory Group, will assist in drawing up such plans. In the 1990s an emphasis on decentralizing immunization and disease control responsibilities in these plans will allow programme implementation and monitoring, including data analysis and timely action, to be taken at the most appropriate local level. This will be facilitated by coordinated efforts to improve district-level management.
27. The establishment and effective functioning of interagency coordinating committees that improve the coordination of donors in support of global, regional and national immunization programmes are needed to assist in the formulation and implementation of such plans and to integrate activities aimed at sustaining primary health care programmes. Such committees should be chaired at the country level by a government official with decision-making authority and would elaborate detailed financial plans which outline the commitments of the national governments and their donor partners over the medium term. They would review programme performance through periodic meetings and make adjustments to the plans and their funding. This coordination benefits both recipients and donor agencies by promoting effective use of available resources and by providing individual donors with the accountability and visibility needed for continuing support. The committees would ideally have a broader mandate for coordination of other primary health care activities to help ensure the best use of resources at the country level by integrating logistics, transport, supervision, and maintenance systems of all programmes.
28. The planning process provides the opportunity for regions, governments and donors to balance global goals, policies and strategies with regional and national priorities. Each region and country set their own priorities based on the magnitude of the disease burden, available resources, expected outcome, and fit within the overall health care goals. Targets and activities will be planned and implemented in a phased manner depending on the degree to which immunization programmes have been developed.
TRAINING
29.
Training is crucial in developing the human resources to plan and implement effectively the activities to meet the goals of the 1990s. Training materials and curricula for the management of immunization programmes and for disease surveillance and control are designed to help strengthen managerial capabilities for implementing primary health care activities. They also ensure that health workers at all levels are equipped to apply national primary health care policies.
30
. Training in the 1990s will increasingly use pre-service education by developing and strengthening curricula in medical, nursing and paramedical schools to ensure that all health workers graduate with sufficient knowledge and skills to implement national immunization policies.
31. Whereas, in the past, in-service training had to concentrate on ways to establish an immunization programme from scratch, in-service training in the 1990s will emphasize problem-solving approaches. Immunization workers will bring their problems and data to workshops, to work out, in collaboration with their colleagues, ways to overcome constraints on programme implementation, and will return with revised plans. In-service training will continue to support the new surveillance focus on disease control and on evolving strategies for outbreak investigation, control and prevention. Efforts will also be made to identify and respond to managerial problems in the delivery of primary health care at the district level.
32. EPI will continue to develop, field test, introduce and revise training materials and curricula based on national, district and community needs. Efforts will be made to join forces with other WHO programmes conducting similar activities. Regional offices and national governments will need to further develop capabilities for timely adaptation, dissemination and implementation of these materials and curricula. 
Challenges for
Keep immunization on the policy-makers' agenda:
Although substantial gains in immunization coverage have been achieved in recent years, policy-makers need to maintain their support of immunization. The obstacles to attaining long-term, sustained impact from immunization programmes will need to be addressed by using communication as an important tool for enlightening policy-makers and programme managers on the changing issues brought about by earlier successes, and on options for future action. Policy-makers will be asked for their continued support to sustain funding, ensure adherence to existing disease control strategies, and encourage innovation in vaccine development and service delivery.
VACCINE SUPPLY AND NEW VACCINES
Vaccine supply is emerging as a priority in the 1990s
. There is an increasing demand for vaccines as immunization coverage rises and as outbreak control and new delivery strategies are implemented to achieve the disease control targets. Costs of vaccines are also increasing. Both these trends have raised concern that additional funds must be forthcoming from national and international sources to assure supply of the quantities of vaccines needed by developing countries to achieve their goals. Rising demand is likely also to require enhanced production capacity.
39. There is also concern about the quality of vaccines. An increasing number of instances are being reported where vaccines have been found to be of poor quality or where infrastructure at the country level is insufficient to assure the maintenance of the relevant WHO standards of quality. Production in developing countries must be based on the proper transfer of technology and the strengthening of national control authorities to monitor quality and good manufacturing practice. Governments and the international community must take urgent steps to assure that all vaccines meet WHO requirements.
40.
A long list exists of additional vaccines, either already in production or still under development, that are suitable for widespread use in developing countries. Finding ways to make them affordable for developing countries is a major challenge. The Children's Vaccine Initiative, enunciated in New York in September 1990, spells out some of the challenges facing immunization programmes in the 1990s: "Work on vaccines themselves must be accompanied by investments which bring them rapidly into large-scale and inexpensive production and effective use. Such investments are needed to simplify production and quality control methods; to support field trials; to speed licensing; to develop approaches -including production in developing countries -which assure that vaccines are available for all; to simplify the logistics of storing, transporting and administering vaccine; and to strengthen national epidemiological and applied research capacities, especially in developing countries, so that each vaccine is used to best advantage".
Hepatitis В vaccine provides an example of the problems encountered when a relatively expensive vaccine is introduced. As a means of long-term control of hepatitis В infection, the EPI Global Advisory
Group has recommended that hepatitis В vaccine should be integrated into national immunization programmes. WHO, UNICEF and others in the international community are seeking ways to bring such vaccines into general use in developing countries. In the 1990s it is a priority for EPI to find alternative solutions to these problems. These include the development of alternative financing schemes to assist the least developed countries, use of the UNICEF tendering process to reduce prices, transfer of technology for local packaging or production, and the Vaccine Independence Initiative to provide a means for purchase of vaccines using non-convertible currencies. It will be a great tragedy if the cost of hepatitis В and other vaccines prevents their use in developing countries, where they could have their greatest impact.
MONITORING AND EVALUATION
42. In the 1990s monitoring of immunization coverage will increasingly be refined to ensure that immunization coverage levels can ultimately be recorded and reported in all communities. Such data will help immunization programmes to identify and direct intensified activities to the underserved population.
43. As immunization coverage levels rise, there will be an increasing focus on disease surveillance to monitor and evaluate programme impact. Such surveillance helps to direct immunization activities to areas of greatest need and is a prerequisite to achieving the goals of measles reduction, neonatal tetanus elimination and of poliomyelitis eradication. Actions such as investigation of outbreaks, application of outbreak control measures, assessment of vaccine efficacy, and review of immunization policies and strategies will be an integral part of these monitoring and evaluation efforts. Progress in surveillance will be assessed by managers responsible for disease surveillance using monitoring indicators such as timeliness and completeness of reporting and promptness of instituting control measures. Since many cases of vaccine-preventable diseases seek treatment in the private sector, establishing and improving surveillance will require close collaboration with private practitioners and their associations.
44. Computerized EPI information systems will be increasingly used as management tools in the 1990s for disease surveillance as well as for monitoring surveillance indicators (e.g., timeliness and completeness of reporting) and immunization coverage. The systems will be progressively expanded and integrated into more generalized health information systems.
45. EPI programme reviews will continue to be promoted in the 1990s. There will be a new emphasis on areas such as management, supervision, training, quality of care, logistics, and disease surveillance that cut across other primary health care activities. EPI indicators will be elaborated and monitored through programme reviews and other methods to assess the extent to which immunization and other primary health care activities support each other. Programme reviews will also focus on solving specific constraints on the programme. 
The World Summit for
A complete list of priority research needs is periodically reviewed by the EPI Research and Development
Group which meets every six months to monitor progress in immunization programme-related research. Many of the research needs have common points with other programmes and increased efforts will be made to share experiences between programmes.
SUSTAINABILITY
49
. The great success of immunization programmes must be sustained and will require continuing intense efforts for the foreseeable future to avoid a resurgence of vaccine-preventable diseases. The unprecedented level of world commitment to improving the well-being of children and women makes this an appropriate time to consider the challenges to sustainabiHty. First, the need for health services never goes away; in every new birth cohort the success of immunization programmes must be repeated. A strong health care infrastructure is needed to continue this recurrent task despite difficulties in maintaining interest and excitement. Secondly, immunization programmes must compete with investments in other health and non-health related areas. Lastly, the quality of care and efficiency in use of programme resources, essential elements of immunization programme sustainability, are inadequate in most countries.
50. Overall programme sustainability is concerned with every activity of an immunization programme. Some of the crucial aspects to be taken into account in the planning and design of all immunization programmes in the 1990s to overcome the above challenges are:
-financial sustainability (where the money will come from; planning for future resources; allocation of resources; and costing programme elements);
• managerial sustainability (using available money and personnel in the most efficient and effective way possible; human resources management that includes maintaining high morale and adequate supervision; district-level planning; monitoring progress toward objectives and targets; equipment maintenance; and logistics);
-political sustainability (fostering the support of the communities served; political, religious and social leaders; and women's organizations); and -technical sustainability (choice of the best policies and appropriate technologies to get the work done efficiently and the training needed to maintain the necessary skills and competence).
51. Research should also be conducted on improved methods for determining the recurrent costs associated with all components of immunization programmes and on devising mechanisms for cost sharing or cost recovery for immunization services.
ROLES AND RESPONSIBIUTIES
52
. National governments will continue to be responsible for coordinating and implementing immunization programmes in their countries. They have been primarily responsible for the achievements of immunization programmes to date, and will continue to be so in the future. Formation and strengthening of technical advisory groups will help to provide recommendations for national immunization programmes. In developing countries, and especially in the least developed countries, donor partners will continue to be needed for the foreseeable future to support governments in achieving universal mother and child immunization and the goals of measles reduction, neonatal tetanus elimination and poliomyelitis eradication. Interagency coordinating committees will play a critical role in coordinating donor input. It is anticipated that in the 1990s an increasing number of organizations, both international and local, will join in the global immunization effort. They would also participate actively in interagency coordinating committees at all appropriate levels. Private physicians will have an increasing role in many countries in providing immunization services, and special efforts will be made to involve medical societies in the recording and reporting of immunizations administered and cases of EPI target diseases diagnosed.
CONCLUSION
62. The past 15 years has witnessed a "quiet revolution" in health. Immunization programmes have been a prime mover in the development of an increasingly effective health infrastructure that is now making some 500 million contacts with infants and mothers each year. The challenges lie in tapping the full potential of these contacts in the decade of the 1990s to control an expanding number of target diseases and to help provide increasingly complete primary health care. The ¿obal coalition built around immunization programmes will serve to further improve immunization and disease control and will act as a catalyst in working to build more comprehensive health services in developing countries. This health infrastructure contributes, in turn, to national development.
63. In addition to the important humanitarian reasons for immunizing, the investment in immunization services makes sound economic, epidemiological and political sense. Disease prevention through immunization reduces not only deaths, but also the need for expensive curative and rehabilitative care. Immunization, in both industrialized and developing countries, will continue to be an important element of national health programmes as new and improved vaccines become available. Each dollar invested will result in an even greater return in prevented medical care costs, disability and death.
64. To these direct benefits are added important indirect benefits: immunization provides a means of helping to break the vicious circle of high infant and childhood mortality rates. Immunization, by permitting more of a family's children to survive, reduces the number of births desired by a family, which, in turn, reduces maternal, infant and child mortality rates. In this way it acts in strong synergy with family planning activities and makes the further expansion of immunization services one of the best bargains available for primary health care and national development.
65. Immunization programmes have entered into a new decade filled with exciting challenges. The continued commitment of governments and the international community to meeting these challenges will move everyone closer to the ultimate vision of a world free of suffering, disability and death from vaccine-preventable diseases. Groups based o n information received from t h e United Nations, January 1 9 9 1 . T h e dassifications a r e f o r analytical purposes only a n d d o n o t have a n y official status. Children u p t o 2 years of age * Tetanus toxoid (mothers) 
